Squamous Cell Carcinoma — Trials

Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,930 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 976
Recruiting: 519
Ph III recruiting: 60
Growth YoY: +44.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 601–601 of 601 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04522687	Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer	recruiting	—	500	Shanghai Cancer Hospital, ChinaOTHER	1	Aug 21, 2020	clinicaltrials